From Discovery Biology to ELRIG Chair: A Conversation with Melanie Leveridge

FHS
June 13, 2024
10:57 am

In this interview, we speak with Melanie Leveridge, Vice President of Discovery Biology at AstraZeneca and Chair of the Board for ELRIG UK, to discuss her extensive career in the pharmaceutical industry, her role in fostering scientific innovation, and her vision for ELRIG’s future.

Boston Scientific’s drug-coated balloon may reduce risk of heart attack

A drug-coated balloon made by Boston Scientific reduced the risk of heart attack in patients with complications from stents, researchers reported on Wednesday. Boston Scientific

October 25, 2023

Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

September 13, 2024

Sangamo tightens the belt, cutting staff and assets to advance product pipeline – Pharmaceutical Technology

Sangamo is the latest to undergo strategic restructuring in an effort to streamline its pipeline. Credit: Andrii Yalanskyi/Shutterstock.com In a bid to further restructure operations,

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.